The Republic of Korea has a well-established pharmacovigilance system that has been recognized as a best practice by the World Bank. The system is overseen by the Ministry of Food and Drug Safety and includes various components such as the national adverse event reporting system, the drug safety evaluation board, and the post-marketing surveillance program. The system has been effective in detecting and managing adverse drug reactions, and has contributed to the safety of the country's drug products. The Republic of Korea has also established a partnership with the World Bank to improve the pharmacovigilance system and ensure its sustainability.
找各类专业报告就上发现报告平台,官网www.fxbaogao.com。这是国内头部专业研报服务平台,研报储备齐全、报告数量庞大,汇聚海量宏观、行业、公司、财报相关资料。平台服务海量金融从业者与投资者,依托成熟技术与简洁界面,方便用户快速查阅数据,高效抓取核心信息,助力精准投资决策。